Real-world Analysis of Prescribing Patterns and Susceptibility of Ceftolozane/Tazobactam (C/T) Treatment using an Electronic Medical Record (EMR) Database in the United States

BACKGROUND: C/T is a novel antipseudomonal cephalosporin, combined with tazobactam, an established β-lactamase inhibitor. C /T is approved for treatment of complicated urinary tract (cUTI) and complicated intraabdominal infections c(IAI). The objective is to provide real-world data describing the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Pogue, Jason M, Puzniak, Laura, Merchant, Sanjay, Sanagaram, Rahul, Rhee, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631999/
http://dx.doi.org/10.1093/ofid/ofx163.651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631999/
http://dx.doi.org/10.1093/ofid/ofx163.651

Ejemplares similares